-
摘要: 组织蛋白酶L (cathepsin L) 是半胱氨酸组蛋白酶家族中的细胞内高效蛋白酶之一, 在部分血管疾病、心脏扩大发生以及冠心病预测等方面发挥了重要作用。因此, 明确组织蛋白酶L在心血管系统中的作用, 对心血管疾病的诊断和治疗有着重要意义。本文对组织蛋白酶L对心血管影响的研究现状做一综述。Abstract: Cathepsin L is an intracellular protease with high potency, which belongs to cysteine cathepsin family.It plays an important role in the pathogenesis of part of vascular diseases, cardiac dilation and prognosis of coronary heart disease.Elucidating the role of cathepsin L in cardiovascular diseases is crucial to the diagnosis and treatment.This review summarizes the current researches about the effects of cathepsin L on cardiovascular system.
-
Key words:
- coronary disease /
- cathepsin L /
- atherosclerosis /
- angiogenesis /
- dilated heart
-
-
[1] JORMSJO S, WUTTGE D M, SIRSJO A, et al.Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprote in E-deficient mice[J].Am J Pathol, 2002, 161:939-945.
[2] SHIRO KITAMOT O, GALINA K, SUKHOV A, et al.Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knock out mice[J].Circulation, 2007, 115:1065-1075.
[3] LI W, KORNMARK L, JONASSON L, et al.Cathepsin L is significantly associated with apoptosis and plaque destabilization in human atherosclerosis[J].Atherosclerosis, 2009, 202:92-102.
[4] CAILHIER J F, ISABELLE S.Caspase-3activation triggers extracellular cathepsin L release and endorepellin proteolysis[J].J Biol Chem, 2008, 283:27220-27229.
[5] HSUEH W A, LAW R E.PPARgamma and atherosclerosis-Effects on cell growth and movement[J].Arterioscl Throm Vas, 2011, 21:1891-1895.
[6] DLER F, DARWEESH M.Peroxisome proliferatoractivated receptor gamma induces apoptosis and inhibits autophagy of human monocyte-derived macrophages via induction of cathepsin L[J].J Biol Chem, 2011, 286:28858-28866.
[7] FATEMEH M, CHRISTINE H J K.Inhibition of lysosomal function in macrophages incubated with elevated glucose concentrations:A potential contributory factor in diabetes-associated atherosclerosis[J].Atherosclerosis, 2012, 223:144-151.
[8] MATTOCK K L, GOUGH P J, HUMPHRIES J, et al.Legumain and cathepsin-L expression in human unstable carotid plaque[J].Atherosclerosi, 2010, 208:83-89.
[9] YUAN X M, OSMAN E, MIAH S, et al.p53 expression in human carotid atheroma is significantly related to plaque instability and clinical manifestations[J].Atherosclerosis, 2010, 210:392-399.
[10] PLATT M O, ANKENY R F.Laminar shear stress inhibits cathepsin l activity in endothelial cells[J].Arterioscler Thromb Vasc Biol, 2006, 26:1784-1790.
[11] PALAZZUOL I, ALBERT O, MADDALEN A, et al.Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm:comparison with high cardiovascular risk population[J].Vascular health and risk management, 2008, 4:877-883.
[12] SUN J S, SUKHOVA G K.Cathepsin L activity Is essential to elastase perfusion-induced abdominal aortic aneurysms in mice[J].Arterioscler Thromb Vasc Biol, 2011, 31:2500-2508.
[13] LIU J, SUKHOVAL G K.Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells[J].Atherosclerosis, 2006, 184:302-311.
[14] SAID A, KEVIN G.Cysteine protease activity in the wall of abdominal aortic aneurysms[J].J Vasc Surg, 2007, 46:1260-1266.
[15] CHUNG J H, KYOUNG IM E.CATHEPSIN L derived from skeletal muscle cells transfected with bFGF promotes endothelial cell migration[J].Exp Mol Med, 2011, 43:179-188.
[16] CARMEN U, ELISABETH D.High glucose reduces cathepsin L activity and impairs invasion of circulating progenitor cells[J].J Mol Cell Cardiol, 2008, 45:429-436.
[17] URBIC H, CARME N, HEESCHE N, et al.Cathepsin L is required for endothelial progenitor cell-induced neovascularization[J].Nat Med, 2005, 11:206-213.
[18] CARMEN U, AYESHA I, DE S, et al.Proteomic characterization of human early pro-angiogenic cells[J].J Mol Cell Cardiol, 2011, 50:333-336.
[19] KEERTHIVASAN S, KEERTHIVASAN G.Transcriptional upregulation of human cathepsin L by VEGF in glioblastoma cells[J].GENE, 2007, 399:129-136.
[20] NORIAKI S, KYOKO O M.Cathepsin L in bone marrow-derived cells is required for retinal and choroidal neovascularization[J].Am J Pathol, 2010, 176:2571-2580.
[21] UTE F, LARS D.Secreted cathepsin L generates endostatin from collagen XVIII[J].EMBO, 2000, 19:1187-1194.
[22] FLORIAN V, AHLAME S, BURDEN R E, et al.Cysteine cathepsins S and L modulate anti-angiogenic activities of human endostatin[J].J Biol Chem, 2011, 286:37158-37167.
[23] ZHANG F, ZHANG Y, LI P L.Dependence of cathepsin L-induced coronary endothelial dysfunction upon activation of NAD (P) H oxidase[J].Microvascular Research, 2009, 78:45-50.
[24] CHEN J, XAVIER S, MOSKOWITZ K, et al.Cathepsin cleavage of sirtuin 1in endothelial progenitor cells mediates stress-induced premature senescence[J].Am J Pathol, 2012, 180:973-983.
[25] IVONNE P, CHRISTIAN M.Lysosomal, cytoskeletal, and metabolic alterations in cardiomyopathy of cathepsin L knockout mice[J].FASEB, 2006, 20:1266-1268.
[26] JÖRG S, KERSTIN G, WERA R, et al.Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L[J].PNAS, 2002, 99:6234-6239.
[27] DANIEL S, JÖRG S.Cell type-specific functions of the lysosomal protease cathepsin L in the heart[J].J Biol Chem, 2007, 282:37045-37052.
[28] TANG Q Z, CAI J, SHEN D F, et al.Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3 β signaling[J].J Mol Med, 2009, 87:249-260.
[29] LIU Y X, LI X P.Usefulness of serum Cathepsin L as an independent biomarker in patients with coronary heart disease[J].Am J Cardiol, 2009, 103:476-481.
[30] ZHANG J, WANG P, HUANG Y B, et al.Plasma cathepsin L and its related pro-antiangiogenic factors play useful roles in predicting rich coronary collaterals in patients with coronary heart disease[J].J Int Med Res, 2010, 38:1389-1403.
[31] MIRZAII-DIZGA H, IRA J, RIAH I, et al.Serum and saliva levels of cathepsin L in patients with acute coronary syndrome[J].JCDP, 2011, 12:114-119.
-
计量
- 文章访问数: 43
- PDF下载数: 25
- 施引文献: 0
下载: